NR4A1 and cancer: Like endocrine therapy, which is indicated specifically by the expression of hormonal receptors in cancer tissue [53, 54], it would be interesting to know if any pathological feature could specifically suggest the sensitivity of tumors to anti-angiogenic reagents.